Female Hair Hirsutism

Eflornithine Hydrochloride 11.5%

Vaniqa is for cutaneous use only. Contact with eyes or mucous membranes (e.g. nose or mouth) should be avoided. those with active cancer or those with 3 years of cancer remission.

Transient stinging or burning may occur when the cream is applied to abraded or broken skin. those with active cancer or those with 3 years of cancer remission.

Do not use in the case of hypersensitivity to the active ingredient or to any of the additional ingredients.

Acne, alopecia, stinging skin, burning skin, dry skin, pruritus, erythema, tingling skin, irritated skin, rash, folliculitis

This medicinal product contains cetostearyl alcohol and stearyl alcohol which may cause local skin reactions (e.g. contact dermatitis) as well as methyl parahydroxybenzoate and propyl parahydroxybenzoate which may cause allergic reactions.

Cetostearyl alcohol; Macrogol cetostearyl ether; Dimeticone; Glyceryl stearate; Macrogol stearate; Methyl parahydroxybenzoate (E218);

Liquid paraffin; Phenoxyethanol; Propyl parahydroxybenzoate (E216); Purified water; Stearyl alcohol; Sodium hydroxide (E524) (to adjust pH)

Vaniqa cream should be applied to the affected area twice daily, at least eight hours apart. Application should be limited to affected areas of the face and under the chin

Do not store above 25°C

Improvement in the condition may be noticed within eight weeks of starting treatment. Continued treatment may result in further improvement and maintain beneficial effects. The condition may return eight weeks after stopping treatment.

If skin irritation or intolerance develops, the frequency of application should be reduced temporarily to once a day. If irritation continues, treatment should be discontinued